Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
ngpeptide.com
NG Peptide holds a Disclosed Labs trust grade of B (85/100), computed independently from 114 lab Certificates of Analysis (as of July 2026). That's a strong, well-documented track record. Scores come only from lab COAs; vendors can't pay to raise them.
What is NG Peptide's trust score?
NG Peptide scores 85/100 (Grade B) on Disclosed Labs, from 114 lab COAs (as of July 2026).
How is NG Peptide's trust score calculated?
Only from lab-issued Certificates of Analysis — average purity, safety-panel coverage, lab corroboration, and forgery signals. No vendor can pay to change it, and sponsorships never affect it.
Samples
Passed
Failed
Trust score updated: July 7, 2026 · 100% pass rate
Composite score based on 114 COAs attributed to this vendor.
Mean HPLC purity across published COAs
Per-peptide coverage of the safety panels each product form requires — identity, net-content, heavy-metals and residual-solvents for raw powders, plus endotoxin and sterility for injectables. Forms aren't penalized for panels they don't need.
Lab corroboration tier — confirmed via public verify portal (90), presumptive trusted lab (85), lab resolved but unverified (75), or no lab attribution (50)
Inverse of CoaFlag count (lot collisions, hash collisions, etc.)
Composite of 114 COAs attributed to this vendor. Last recomputed 2026-07-07.
| Date | Peptide | Test | Result | Purity | Lab | Notes |
|---|---|---|---|---|---|---|
| Jun 25, 2026 | MT-2 | HPLC purity | PASS | 99.88% | ILS Labs | Lot mt10-04 · Report ACC-2026-4523 |
| Jun 25, 2026 | Retatrutide | HPLC purity | PASS | 99.94% | ILS Labs | Lot rt30-6174 · Report ACC-2026-4524 |
| Jun 25, 2026 | NAD+ | HPLC purity | PASS | 99.29% | ILS Labs |
Research profiles — side effects, mechanism, and lab-tested COA data for each peptide in this vendor's catalog.
Add a live, data-driven trust badge to your site or review. It updates automatically when new COAs are indexed — no account required.
Preview
Live badge (JavaScript)
<script async src="https://www.disclosedlabs.com/widget.js" data-vendor="ng-peptide"></script>
Renders the dynamic grade badge. Best visual; the link is injected by script.
Static link (HTML) — best for SEO
<a href="https://www.disclosedlabs.com/vendors/ngpeptide.com" rel="noopener" target="_blank" style="display:inline-flex;align-items:center;gap:8px;padding:8px 12px;border:1px solid #e2e8f0;border-radius:10px;background:#fff;color:#0f172a;text-decoration:none;font:600 13px/1.25 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Helvetica,Arial,sans-serif"> ✓ Verified by Disclosed Labs — independent COA trust score </a>
A plain, crawlable dofollow link in your page source. This is the version search engines credit.
Both point to NG Peptide's live profile at https://www.disclosedlabs.com/vendors/ngpeptide.com.
Links back to NG Peptide's profile — a dofollow link (no sponsored or nofollow tagging). Score updates daily. Dark theme & options →
| 5-Amino-1MQ | vial | 5mg | $20.00 | $4.00 | Sold out | 2026-07-08 | View → |
| 5-Amino-1MQ | vial | 50mg | $50.00 | $1.00 | In stock | 2026-07-08 | View → |
| AHK-Cu | vial | 100mg | $30.00 | $0.30 | Sold out | 2026-07-08 | View → |
| AOD-9604 | vial | 50mg | $200.00 | $4.00 | Sold out | 2026-07-08 | View → |
| BPC-157 | vial | 10mg | $30.00 | $3.00 | In stock | 2026-07-08 | View → |
| BPC-157 | vial | 20mg | $55.00 | $2.75 | Sold out | 2026-07-08 | View → |
| BPC-157 | vial | 30mg | $120.00 | $4.00 | Sold out | 2026-07-08 | View → |
| BPC-157 + TB-500 | blend | 10mg | $55.00 | $5.50 | In stock | 2026-07-08 | View → |
| BPC-157 + TB-500 | blend | 100mg | $65.00 | $0.65 | In stock | 2026-07-08 | View → |
| Cagrilintide | vial | 5mg | $40.00 | $8.00 | In stock | 2026-07-08 | View → |
| Cagrilintide | vial | 10mg | $65.00 | $6.50 | In stock | 2026-07-08 | View → |
| CJC-1295 + Ipamorelin (No DAC) | blend | 10mg | $40.00$50.00 | $4.00 | In stock | 2026-07-08 | View → |
| GHK-Cu | vial | 50mg | $20.00 | $0.40 | In stock | 2026-07-08 | View → |
| GLOW Blend (GHK-Cu + BPC-157 + TB-500) | blend | 70mg | $389.99 | $5.57 | In stock | 2026-07-08 | View → |
| Glutathione | vial | 1500mg | $45.00 | $0.03 | Sold out | 2026-07-08 | View → |
| Ipamorelin | vial | 5mg | $28.00 | $5.60 | Sold out | 2026-07-08 | View → |
| Ipamorelin | vial | 10mg | $42.00 | $4.20 | In stock | 2026-07-08 | View → |
| Melanotan II | vial | 10mg | $24.99 | $2.50 | In stock | 2026-07-08 | View → |
| MOTS-c | vial | 40mg | $80.00 | $2.00 | In stock | 2026-07-08 | View → |
| NAD+ | vial | 500mg | $50.00 | $0.10 | Sold out | 2026-07-08 | View → |
| NAD+ | vial | 5000mg | $340.00 | $0.07 | Sold out | 2026-07-08 | View → |
| PT-141 | vial | 10mg | $24.99 | $2.50 | Sold out | 2026-07-08 | View → |
| Retatrutide | vial | 10mg | $42.00 | $4.20 | In stock | 2026-07-08 | View → |
| Retatrutide | vial | 20mg | $68.00 | $3.40 | In stock | 2026-07-08 | View → |
| Retatrutide | vial | 30mg | $95.00 | $3.17 | In stock | 2026-07-08 | View → |
| Retatrutide | vial | 50mg | $165.00 | $3.30 | In stock | 2026-07-08 | View → |
| Semax | vial | 10mg | $35.00 | $3.50 | In stock | 2026-07-08 | View → |
| Semax | nasal | 50mg | $140.00 | $2.80 | Sold out | 2026-07-08 | View → |
| Sermorelin | vial | 10mg | $45.00 | $4.50 | Sold out | 2026-07-08 | View → |
| TB-500 | vial | 10mg | $35.00 | $3.50 | Sold out | 2026-07-08 | View → |
| TB-500 | vial | 20mg | $64.00 | $3.20 | Sold out | 2026-07-08 | View → |
| Tesamorelin | vial | 10mg | $50.00 | $5.00 | In stock | 2026-07-08 | View → |
| Tesamorelin | vial | 20mg | $90.00 | $4.50 | Sold out | 2026-07-08 | View → |
| Tesamorelin + Ipamorelin | blend | 13mg | $60.00 | $4.62 | Sold out | 2026-07-08 | View → |
| Tesamorelin + Ipamorelin | blend | 12mg | $75.00 | $6.25 | In stock | 2026-07-08 | View → |
| Tirzepatide | vial | 20mg | $65.00 | $3.25 | In stock | 2026-07-08 | View → |
| Tirzepatide | vial | 40mg | $100.00 | $2.50 | In stock | 2026-07-08 | View → |
| Tirzepatide | vial | 30mg | $350.00 | $11.67 | In stock | 2026-07-08 | View → |
| Tirzepatide | vial | 60mg | $580.00 | $9.67 | Sold out | 2026-07-08 | View → |
| Vasoactive Intestinal Peptide (VIP) | vial | 5mg | $40.00 | $8.00 | In stock | 2026-07-08 | View → |
| Vasoactive Intestinal Peptide (VIP) | vial | 10mg | $45.00 | $4.50 | In stock | 2026-07-08 | View → |
Prices are scraped from ngpeptide.comand may lag the live site. All prices are single-vial / pre-bulk list prices — bulk or bundle deals may be lower. $/mg is derived from the listed strength. “Updated” is when we last verified each listing.
We are continuously testing more products. Scores update with each new result.
Read our scoring methodology →Trust scores are computed from indexed Certificates of Analysis — vendor-published, and lab-confirmed where a lab copy verifies them — using a fixed, versioned methodology (v16). They are not based on independent blind-purchase testing, and no vendor can pay for placement or a higher score. How we score · How we make money
| Lot NSP-NAD-01 · Report COA-2026-WKZZDO |
| Jun 25, 2026 | GLOW | HPLC purity | PASS | 99.86% | ILS Labs | Lot glw70-10 · Report ACC-2026-4536 |
| Jun 25, 2026 | Sermorelin | HPLC purity | PASS | 99.93% | ILS Labs | Lot sm10-05 · Report ACC-2026-4527 |
| Jun 25, 2026 | Tesamorelin | HPLC purity | PASS | 99.97% | ILS Labs | Lot tsm20-04 · Report ACC-2026-4530 |
| Jun 25, 2026 | BPC-157/TB500 | HPLC purity | PASS | 99.88% | ILS Labs | Lot bptb20-08 · Report ACC-2026-4542 |
| Jun 25, 2026 | KLOW | HPLC purity | PASS | 99.84% | ILS Labs | Lot klw06 · Report ACC-2026-4533 |
| Jun 12, 2026 | BPC+TB 20MG | HPLC purity | PASS | 99.82% | ILS Labs | Lot BPTB20-05 · Report ACC-2026-4512 |
| Jun 12, 2026 | MOTS-C | Identity & safety panels | PASS | -- | ILS Labs | Lot MTC-LD-01 · Report COA-2026-TZ6FMA |
| Jun 9, 2026 | CJC-1295 (No DAC)/ Ipamorelin | HPLC purity | PASS | 99.67% | ILS Labs | Lot CJPA-04 · Report ACC-2026-3642 |
| Jun 9, 2026 | Tirzepatide | HPLC purity | PASS | 99.88% | ILS Labs | Lot TRZ30-13 · Report ACC-2026-3640 |
| Jun 9, 2026 | Retatrutide | HPLC purity | PASS | 99.14% | ILS Labs | Lot RT10-17 · Report ACC-2026-3639 |
| Jun 8, 2026 | KLOW BLEND | HPLC purity | PASS | 99.92% | ILS Labs | Lot KLW-06 · Report ACC-2026-3641 |
| Jun 5, 2026 | Selank | Identity & safety panels | PASS | -- | ILS Labs | Lot NSP-SLK-01 · Report ACC-2026-3615 |
| Jun 5, 2026 | BPC-157 | HPLC purity | PASS | 99.96% | ILS Labs | Lot BPC20-05 · Report ACC-2026-3620 |
| Jun 5, 2026 | Tirzepatide | HPLC purity | PASS | 99.9% | ILS Labs | Lot TRZ60-04 · Report ACC-2026-3621 |
| Jun 5, 2026 | GHK-Cu / KPV | HPLC purity | PASS | 99.86% | ILS Labs | Lot GHKPV-02 · Report ACC-2026-3619 |
| Jun 5, 2026 | Semax | Identity & safety panels | PASS | -- | ILS Labs | Lot NSP-SMX-01 · Report COA-2026-ICT4O_ |
| Jun 1, 2026 | GLP-3 | HPLC purity | PASS | 99.89% | ILS Labs | Lot RT50-01 · Report ACC-2026-3193 |
| May 25, 2026 | SLU-PP-322 | Identity & safety panels | PASS | -- | ILS Labs | Lot SLP-01-LD · Report ACC-2026-2065 |
| May 25, 2026 | KLOW | Identity & safety panels | PASS | -- | ILS Labs | Lot KLW-01-LD · Report COA-2026-MDSKEE |
| May 25, 2026 | AOD 9604 | Identity & safety panels | PASS | -- | ILS Labs | Lot AD-01-LD · Report ACC-2026-2061 |
| May 25, 2026 | BPC-157 | Identity & safety panels | PASS | -- | ILS Labs | Lot BC-01-LD · Report ACC-2026-2062 |
| May 24, 2026 | 5 Amino 1mq | HPLC purity | PASS | 99.98% | ILS Labs | Lot 5AM-CAP-02 · Report ACC-2026-2784 |
| May 24, 2026 | BPC+TB 20MG | HPLC purity | PASS | 99.95% | ILS Labs | Lot BPTB-07 · Report ACC-2026-2780 |
| May 23, 2026 | SLU-PP-332 | HPLC purity | PASS | 99.21% | ILS Labs | Lot SLP-CAP-02 · Report ACC-2026-2788 |
| May 23, 2026 | ADAMAX | HPLC purity | PASS | 99.8% | ILS Labs | Lot ADX-02 · Report ACC-2026-3089 |
| May 23, 2026 | MOTS-C | HPLC purity | PASS | 99.04% | ILS Labs | Lot MTS40-07 · Report ACC-2026-2770 |
| May 22, 2026 | KPV | HPLC purity | PASS | 99.72% | ILS Labs | Lot KP10-05 · Report ACC-2026-2771 |
| May 12, 2026 | Tesa/IPA/CJC | HPLC purity | PASS | 99.92% | ILS Labs | Lot TIC336-01 · Report ACC-2026-1760 |
| May 10, 2026 | Tesamorelin | HPLC purity | PASS | 99.48% | ILS Labs | Lot TSM20-3 · Report ACC-2026-2110 |
| May 10, 2026 | BPC+TB 5/5 | HPLC purity | PASS | 99.31% | ILS Labs | Lot BPTB10-4 · Report ACC-2026-2114 |
| May 10, 2026 | NAD | HPLC purity | PASS | 99.83% | ILS Labs | Lot ND500-4 · Report ACC-2026-2115 |
| May 10, 2026 | 5-AMINO-MQ | HPLC purity | PASS | 99.72% | ILS Labs | Lot AM50-3 · Report ACC-2026-2113 |
| May 10, 2026 | TB-500 | HPLC purity | PASS | 99.87% | ILS Labs | Lot TB20-5 · Report ACC-2026-2111 |
| May 7, 2026 | GLOW (GHK-Cu + BPC-157 + TB-4 blend) | HPLC purity | PASS | 99.88% | ILS Labs | Lot GLW70-09 · Report COA-2026-CA5XDZ |
| May 7, 2026 | BPC-157 | HPLC purity | PASS | 99.28% | ILS Labs | Lot BC10-07 · Report ACC-2026-1768 |
| May 7, 2026 | Ipamorelin | HPLC purity | PASS | 99.64% | ILS Labs | Lot IPA10-01 · Report ACC-2026-1756 |
| May 6, 2026 | Cagrilintide | HPLC purity | PASS | 99.85% | ILS Labs | Lot CG10-12 · Report ACC-2026-1781 |
| May 6, 2026 | Semax | HPLC purity | PASS | 99.77% | ILS Labs | Lot SMX-09 · Report COA-2026-SMB9FY |
| May 6, 2026 | TB-500 | HPLC purity | PASS | 99.85% | ILS Labs | Lot TB10-07 · Report COA-2026-GVLIWM |
| May 6, 2026 | Tirzepatide | HPLC purity | PASS | 99.92% | ILS Labs | Lot TRZ20-13 · Report ACC-2026-1770 |
| May 6, 2026 | ADAMAX | HPLC purity | PASS | 99.69% | ILS Labs | Lot ADX-01 · Report ACC-2026-1793 |
| May 6, 2026 | Tirzepatide | HPLC purity | PASS | 99.89% | ILS Labs | Lot TRZ30-12 · Report ACC-2026-1797 |
| May 6, 2026 | Thymosin Alpha 1 | HPLC purity | PASS | 99.68% | ILS Labs | Lot TA1-04 · Report ACC-2026-1801 |
| May 6, 2026 | Tirzepatide | HPLC purity | PASS | 99.93% | ILS Labs | Lot TRZ40-14 · Report COA-2026-1FNKGS |
| Apr 23, 2026 | BPC-157/TB-500 blend | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot BPTB20-06 · Report #151336 |
| Apr 23, 2026 | Tesamorelin | HPLC purity | PASS | 99.676% | Janoshik Analytical | Lot TSM10-13 · Report 147067 |
| Apr 21, 2026 | GHK-Cu | HPLC purity | PASS | 99.89% | ILS Labs | Lot GHK-12 · Report COA-2026-4RN2FB |